Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kisqali
Pharma
Novartis CEO eyes 2026 growth despite record patent cliff
Despite a $4 billion revenue hole from the “largest patent expiry” in Novartis’ history, CEO Vas Narasimhan insisted that Novartis will grow in 2026.
Angus Liu
Feb 4, 2026 2:30pm
Newer drugs came to Novartis' aid as top-selling brands stalled
Oct 28, 2025 11:18am
ESMO: Eli Lilly looks to drive Verzenio adoption with survival win
Oct 17, 2025 8:00am
Lilly answers Novartis breast cancer rivalry with survival win
Aug 27, 2025 10:59am
Novartis' Pluvicto picks up speed, delivers another trial win
Jul 17, 2025 10:56am
RemeGen, Roche, Hengrui and more—Fierce Pharma Asia
May 16, 2025 10:20am
